![Figure 1. Proposed pathway of compound A metabolism (from previous reports [14–16,18]). Covalent binding of thionoacyl fluoride and thioketene intermediates is based on the findings of Martin and associates. [37]](https://asa2.silverchair-cdn.com/asa2/content_public/journal/anesthesiology/86/1/10.1097_00000542-199701000-00020/2/20ff1.png?Expires=1716278971&Signature=oE9pfzAH~IuCrSeQjRhaqpVxje83jIAi60TpAtolWlMZEATXiaNANTzVl3p9UMnx8D~W1Amr83pmRMq8QrJfPCjqserMiaJfl24-zjMO58bYkL6JFsUIxDNjTrEeWCyTIVW3oLwPu0futWkaEMjPmpf~UdjdLoylcq9fh8Zz36nPczEzVyTYlouhgP3ObdIAFbvJ-INSZScxKUrkna4prUz8Ls3NIVOgv3TTG5iAnmED5oRabnv94SCzeza8xZlnyj~vhRblRpLL8bILXSPsPqEnFYxVkUIVWErNvRWj0tN8NDHW84pKkDL22Yoh9ZWJTz5pZ9DsH0-ZboVRT-p03A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Figure 1. Proposed pathway of compound A metabolism (from previous reports [14–16,18]). Covalent binding of thionoacyl fluoride and thioketene intermediates is based on the findings of Martin and associates. [37]
Figure 1. Proposed pathway of compound A metabolism (from previous reports [14–16,18]). Covalent binding of thionoacyl fluoride and thioketene intermediates is based on the findings of Martin and associates. [37]
